| Cash Flow | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-09-28 |
|---|---|---|---|---|
| Purchase of treasury stock | 360,577 | 360,484 | 353,132 | 119,051 |
| Payments of contingent consideration | 21,822 | 21,822 | - | 0 |
| Purchase of remaining equity interest of other redeemable noncontrolling interests | 19,140 | 19,140 | 19,140 | 12,000 |
| Other, net | -12,687 | -6,458 | 0 | -26,900 |
| Net cash used in financing activities | -484,862 | -332,246 | -105,325 | -475,048 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 14,900 | 17,934 | 5,265 | -4,025 |
| Net change in cash, cash equivalents, and restricted cash | 3,650 | -20,830 | 26,158 | -72,840 |
| Cash and cash equivalents at beginning of period | 205,570 | 205,570 | 205,570 | 284,480 |
| Cash and cash equivalents at end of period | 209,220 | 184,740 | 231,728 | 211,640 |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)